Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease.

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Abstract Text:

Cholelithiasis is a multifactorial process, and several mechanisms have been postulated. A decreased expression of the ileal apical sodium-dependent bile acid transporter (ASBT) and of the cytosolic ileal lipid binding protein (ILBP) was recently described in female non-obese patients. The role of the recently identified organic solute transporters alpha and beta (OSTalpha, OSTbeta) in gallstone pathogenesis remains unclear. Therefore, we performed analysis of OSTalpha-OSTbeta in gallstone patients according to body weight. Ileal mucosal biopsies were collected during routine colonoscopy from female gallstone carriers (n = 19) and controls (n = 34). OSTalpha-OSTbeta mRNA expression was measured using the LightCycler sequence detection system; protein was analyzed by immunohistochemistry and Western blot. The mRNA expression of OSTalpha-OSTbeta was significantly reduced (OSTalpha: 3.3-fold, P = 0.006; OSTbeta: 2.6-fold, P = 0.03) in normal-weight but not overweight gallstone carriers compared with controls. OSTalpha-OSTbeta protein levels also showed a reduction by 40-67%. The expression of OSTalpha-OSTbeta correlated positively with ASBT (r = 0.65, 0.58, respectively), ILBP (r = 0.77, 0.67), and the farnesoid X receptor (r = 0.58, 0.50). Fibroblast growth factor-19 showed a 2.8-fold reduction (P = 0.06), and liver receptor homolog-1 showed a 2-fold reduction (P = 0.04) in non-obese patients. In conclusion, an impaired function of all three ileal bile acid transporters may lead to low ileal bile acid reabsorption and an altered bile acid pool composition and therefore may contribute to the formation of gallstones in non-obese patients.

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of lipid research

VOLUME: 49

Page Numbers: 2045-54

Journal Abbreviation: J. Lipid Res.

ISSN: 0022-2275

DAY: 9

MONTH: 05

YEAR: 2008

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376606

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease.

AFFILIATION: Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tübingen, Germany.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Lipid Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease Related Publications

• An appreciative inquiry approach to practice improvement and transformative change in health care settings.
• Association of intervention outcomes with practice capacity for change: Subgroup analysis from a group randomized trial.
• Cholesterol reduction using psyllium husks - Do gastrointestinal adverse effects limit compliance? Results of a specific observational study.
• Crohn's disease-Defect in innate defence.
• Curiosity and context revisited: crassulacean acid metabolism in the Anthropocene.
• Directional selectivity in the simple eye of an insect.
• GC-R-CF-MS method to determine the 13C abundance of gaseous combustion products in cigarette smoke.
• How effective is natalizumab induction therapy in patients with Crohn's disease?
• Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease.
• The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
• The promise and pitfalls of generalism in achieving the Alma-Ata vision of health for all.
• [A contribution to the histogenesis of the hilus cells.]
• [A contribution to the normal and pathological anatomy of the ovarian rete.]
• [AM I REALLY STUPID?EXCERPTS FROM A PSYCHAGOGIC TREATMENT.]
• [Comparative morphological studies on the fallopian tube in its maximal functional state to clarify the question of an existing infundibular sphincter?]
• [Disgerminoma and intersexuality.]
• [Experimental study on labor readiness and possibilities of its control.]
• [Inflammatory bowel diseases--new therapeutic options]
• [Is the small step method useful to us? Productivity Training Corporation (PTC) from the users' viewpoint]
• [Recurring glomus tumors of the preputium clitoridis.]
• [Stoma care service is required in Norway]
• [Therapy of chronic inflammatory bowel diseases]
• [Tumor development in gonadal abnormalities & its significance for therapeutic progress.]
• [Value of stimulation-excitation lines acoustically evoked for speech discrimination in children]